Objective: For optimized expansion of human-induced pluripotent stem cells (hiPSCs) with regards to clinical applications, we investigated the influence of the inoculum density on the expansion procedure in 3D hollow-fibre bioreactors.
| INTRODUC TI ON
The application of human-induced pluripotent stem cells (hiPSCs) has shown high potential in the field of clinical therapies 1 and pharmaceutical drug development, 2 as this cell type is suitable for generating disease-specific models and patient-specific therapies. [3] [4] [5] [6] However, the utilization of hiPSC models in drug discovery requires high cell quantities of hiPSCs and their derivatives at a constant quality. 7, 8 This can hardly be achieved by using conventional 2D cell cultures due to insufficient cell production yields, lack in scalability and difficulty of controlling cell culture parameters. 9, 10 In contrast, the use of 3D culture models offers the opportunity of large-scale expansion of hiPSCs under controlled conditions. 9, 11 For production of large cell quantities fulfilling the required quality standards, it is important to consider those factors that potentially influence hiPSC expansion and differentiation in 3D culture systems. Such factors include feeding strategies, coating materials, culture media and the cell inoculum density. 9 In the present study, the effect of the inoculum density on cell expansion and differentiation of hiPSCs cultured in perfused hollowfibre-based 3D bioreactors was investigated. For this purpose, 10 × 10 6 hiPSCs resp. 3.3 × 10 6 cells/mL, or 50 × 10 6 hiPSCs resp.
16.6 × 10 6 cells/mL were inoculated into analytical-scale bioreactors with a cell compartment volume of 3 mL (AS) and cultured over a period of 15 days. Both conditions were compared in terms of biochemical parameters, cell activity and cell yields, gene expression analysis and immunohistochemical staining. Changes in the differentiation state of hiPSCs expanded in bioreactors were detected by gene expression and immunofluorescence analysis, where hiPSCs forming embryoid bodies served as differentiation control. The feasibility of scaling up of hiPSC expansion was tested in a large-scale 3D bioreactor with a cell compartment volume of 17 mL (LS) using an inoculation number of 50 × 10 6 cells, resp.
2.9 × 10 6 cells/mL.
| MATERIAL S AND ME THODS

| Bioreactor system/technology
The 3D four-compartment hollow-fibre bioreactor used in this study is based on three independent, interwoven hollow-fibre capillary bundles, two for supplying nutrient media by countercurrent perfusion and one for gas exchange. The space between these capillary bundles (extracapillary space) serves as cell compartment. The capillary system is integrated into a polyurethane housing. The cells, grown in the cell compartment, were constantly supplied with nutrients and oxygen. The bioreactor types used in this study had a cell compartment volume of 3 mL (analytical-scale, AS) or 17 mL (largescale, LS); specific data regarding compartment measurements as well as perfusion conditions are displayed in Table 1 . Both bioreactor types, the AS and LS bioreactor, are constructed identically in respect of their capillary configuration ( Figure 1) ; they only differ in length and number of capillaries. A detailed description of the bioreactor technology can be found elsewhere. 12, 13 The bioreactors were connected to a perfusion device consisting of pumps for medium feed and medium recirculation.
| Pre-expansion of hiPSCs in 2D cultures
The hiPSC line DF6-9-9T 14 
| Expansion of hiPSCs in 3D bioreactors
Following pre-expansion, either 10 × 10 6 (AS 10) or 50 × 10 6 (AS 50, LS 50) hiPSCs were inoculated as single-cell suspension into precoated bioreactors (8.68 µg/cm 2 Matrigel, Corning) and cultured over 15 days. The initial cell numbers used in this study are based on previous studies on the hepatic differentiation of hiPSCs in the AS bioreactor, where 100 × 10 6 cells were inoculated. 15 Thus, an initial cell number of 10 × 10 6 cells, resp. 3.3 × 10 6 cells/mL in AS 10 provides the spatial conditions for at least a 10-fold cell expansion, while an initial cell number of 50 × 10 6 resp. a cell density of 16.6 × 10 6 cells/mL in AS 50 should enable at least a 2-fold expansion. The latter was chosen to investigate the influence of a high initial cell density on the expansion procedure. For the feasibility testing of an up-scale of the hiPSC expansion, the LS bioreactor was inoculated with a cell number of 50 × 10 6 resp. a cell density of 2.9 × 10 6 cells/mL, as this equals the conditions of AS 10. To ensure single-cell survival at the beginning of the experiment, 1 mmol/L ROCK inhibitor (Y-27632; Abcam) was included into the culture medium as bolus injection and was rinsed out within the first 24 hours of bioreactor cultures.
The bioreactors were placed into a heating chamber constantly kept at 37°C. The medium recirculation rate was set to 10 mL/min (AS) resp. 20 mL/min (LS), whereas the medium feed was initially set to 1 mL/h (AS) resp. 2 mL/h (LS) and adapted daily to up to 12 mL/h (AS) or 40 mL/h (LS), depending on the glucose consumption rates.
Thereby, glucose levels were kept above 4.4 mmol/L throughout the culture period. The gas perfusion rate was constantly maintained at 20 mL/min (AS) resp. 40 mL/min (LS); CO 2 was added at a percentage of up to 5% for pH regulation to approximately 7.2 (Table 1) . 
| Biochemical parameters
The metabolic activity of cultured cells was analysed by daily measurements of biochemical parameters in samples from the recirculating medium. Glucose and lactate concentrations were determined by means of a blood gas analyser (ABL 700; Radiometer, Copenhagen, Denmark The schematic image on top shows a section of the capillary structure inside the bioreactor, consisting of the following four compartments: medium capillaries I (red) and II (blue) for countercurrent medium perfusion, gas capillaries (yellow) and the space surrounding the capillaries, which serves as the cell compartment (white). The scale bars correspond to 2 cm
| Embryoid body formation
staining. Also, the mTeSR medium was replaced with E6-me- 
| Gene expression analysis
Gene expression analysis was performed as described previously 15, 17 using human-specific primers and probes as listed in Table 2 .
Expression values of measured genes were normalized to expression values of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and fold changes of expression levels were calculated using the ΔΔC t method. 
| Immunhistochemistry analysis
Upon termination of bioreactor cultures, sections of the capillary bed containing cell material were removed and prepared for immunofluorescence staining as described previously. 19 Nuclei were counterstained with Dapi (blue). The antibodies used for immunohistochemistry are displayed in Table 3 .
| Statistical evaluation
Statistical analysis was performed using GraphPad Prism 7.0 for Windows (GraphPad Software, SanDiego, CA, USA). Data are presented as means ± standard error of the mean (SEM) from three or four runs at each inoculum density for AS, or as single values for LS.
For evaluation of differences in growth behaviour between AS 10 and AS 50, the areas under curves (AUCs) and the tipping points (ie time when peak values of the curves were reached) were calculated and compared using the unpaired, two-tailed Student's t test. Gene expression data were compared between AS 10 and AS 50, corresponding 2D cultures and embryoid bodies by one-way analysis of variance (ANOVA). Slope values obtained in the CellTiter-Blue ® Cell
Viability Assay as well as cell quantification data, population doublings and doubling times were compared using the unpaired, twotailed Student's t test. Figure 2D ). In contrast, there was no AFP detectable in perfusates of AS 10 during the entire culture period ( Figure 2D ). For LS 50 ( Figure 2H ), a slight increase was measured from day 14 onwards, but maximum values were almost five times lower than those observed in AS 50.
| RE SULTS
| Metabolic activity of hiPSCs during bioreactor expansion
In conclusion, higher cell densities led to a significantly higher overall cell activity in AS bioreactors; however, higher cell densities also led to beginning differentiation as indicated by increasing AFP levels in AS 50. The highest values for energy metabolism were achieved in LS 50, being more than three times as high compared
with maximum values obtained in AS 50.
| Gene expression profiles of hiPSC cultures
For the characterization of hiPSCs after expansion in 3D bioreactors, the gene expression of pluripotency as well as differentiation markers relative to the undifferentiated state were analysed.
The expression data of the two pluripotency markers POU5F1 and NANOG ( Figure 3A To summarize, gene expression profiles indicate beginning differentiation processes in bioreactor cultures, which were most pronounced in AS 50. However, in embryoid bodies, the expression of both pluripotency markers was lower, and expression of the majority of differentiation markers was higher compared with the bioreactor cultures.
| Cell activity of hiPSC cultures
The CellTiter-Blue ® Cell Viability assay (CTB) was performed in all bioreactors as well as in 2D cultures, which were cultured in paral- In conclusion, the highest cell activity was detectable in LS 50, followed by AS 50 and AS 10. The increase in cell activity of AS 50
was significantly larger than that of AS 10.
| Immunohistochemical characteristics of hiPSC cultures
Staining with the pluripotency marker POU5F1 ( 
| Proliferation yields of hiPSCs expanded in bioreactors or 2D cultures
Based on the results of the CTB and a corresponding calibration curve obtained from 2D cultures (data not shown), cell numbers were determined on the final day of the bioreactor experiments or the final day of 2D cultures (Table 4) To conclude, a more than 100-fold increase in cell number was achieved in AS 10 and LS 50, whereas a 28-fold increase was reached in AS 50. Population doublings and doubling times reflected these results.
| D ISCUSS I ON
Since the application of hiPSCs in the medical field requires large cell quantities at high-quality standards, it is of great interest to evaluate factors that influence hiPSC expansion in 3D culture systems. Therefore, the effect of the inoculum density on the hiPSC expansion procedure, cell differentiation and the cell yield was investigated in this study. 
(GATA2, [H]) and T-Box Transcription Factor T (T, [I])
. Expression data were normalized to the housekeeping gene Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH), and n-fold expression values were calculated relative to undifferentiated hiPSCs before inoculation on d0 using the ΔΔC t method. Data are presented as mean ± SEM (AS 10 n = 3; AS 50 n = 3; LS 50 n = 1; 2D d15 n = 5; EB's d15 n = 3). Differences between AS 10, AS 50 as well as 2D cultures and embryoid bodies were detected using the one-way ANOVA; calculated values were considered significant at *P < 0.05, **P < 0.01 and ***P < 0.001 (2D d15, n = 4). Differences in the gradients of the corresponding linear correlation were detected using the unpaired, two-tailed Student's t test and considered statistically significant at *P < 0.05 and **P < 0.01 5 × 10 4 hiPS cells/mL for expansion in stirred bioreactors. In these studies, hiPSC proliferation by the 4-to 6-fold was observed, reaching 2 × 10 6 to 3.5 × 10 6 cells/mL. 35, 36 In contrast, Lei et al 37 48 In particular, the four-compartment hollow-fibre bioreactors used in this study aim to mimic the in vivo situation in the tissue, thereby enabling increased cell densities at physiological levels. 17 Therefore, the results gained in 2D cultures may not be directly comparable to the 3D cultures used in the present study. imum values for the glucose uptake and growth, but also to cells more prone to differentiation. In contrast, lower initial cell numbers led to slower expansion, but showed less differentiation and required less time and effort for pre-expansion of the inoculum to the 3D bioreactor. The latter is especially of relevance for efficient hiPSC expansion in large-scale bioreactors. Based on the described results, we conclude that 3D perfusion bioreactors should be inoculated with low cell numbers for achieving a successful long-term hiPSC expansion for clinical purposes. In order to avoid differentiation, additional repeated cell harvesting or cell aggregate dissociation may be included into the expansion procedure.
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